Hypermarcas SA is a leading consumer goods company in Brazil. The company is present in pharmaceuticals and personal care. The company's pharmaceuticals products include over-the-counter medications, generic drugs and prescription medications. The c... More
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
AMAR REMEDIES Jun-12 |
HYPERMARCAS Dec-14 |
AMAR REMEDIES/ HYPERMARCAS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 164 | 278 | - | |
Low | Rs | 86 | 203 | - | |
Sales per share (Unadj.) | Rs | 261.6 | 94.8 | - | |
Earnings per share (Unadj.) | Rs | 17.4 | 8.3 | - | |
Cash flow per share (Unadj.) | Rs | 22.3 | 10.6 | - | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Dividend yield (eoy) | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 100.7 | 151.4 | - | |
Shares outstanding (eoy) | m | 26.16 | 635.00 | - | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 0.5 | 2.5 | 18.8% | |
Avg P/E ratio | x | 7.2 | 28.8 | 24.9% | |
P/CF ratio (eoy) | x | 5.6 | 22.8 | 24.6% | |
Price / Book Value ratio | x | 1.2 | 1.6 | 78.1% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 3,270 | 152,706 | 2.1% | |
No. of employees | `000 | NA | 12.9 | 0.0% | |
Total wages/salary | Rs m | 163 | 2,945 | 5.5% | |
Avg. sales/employee | Rs Th | NM | 4,652.9 | - | |
Avg. wages/employee | Rs Th | NM | 227.7 | - | |
Avg. net profit/employee | Rs Th | NM | 409.6 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 6,844 | 60,185 | 11.4% | |
Other income | Rs m | 21 | 1,016 | 2.1% | |
Total revenues | Rs m | 6,865 | 61,201 | 11.2% | |
Gross profit | Rs m | 1,131 | 14,526 | 7.8% | |
Depreciation | Rs m | 128 | 1,409 | 9.1% | |
Interest | Rs m | 398 | 7,665 | 5.2% | |
Profit before tax | Rs m | 626 | 6,469 | 9.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -50 | -129 | 38.9% | |
Tax | Rs m | 121 | 1,042 | 11.6% | |
Profit after tax | Rs m | 455 | 5,298 | 8.6% | |
Gross profit margin | % | 16.5 | 24.1 | 68.5% | |
Effective tax rate | % | 19.3 | 16.1 | 120.0% | |
Net profit margin | % | 6.6 | 8.8 | 75.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 4,904 | 62,050 | 7.9% | |
Current liabilities | Rs m | 3,581 | 38,439 | 9.3% | |
Net working cap to sales | % | 19.3 | 39.2 | 49.3% | |
Current ratio | x | 1.4 | 1.6 | 84.8% | |
Inventory Days | Days | 124 | 52 | 241.0% | |
Debtors Days | Days | 100 | 121 | 82.6% | |
Net fixed assets | Rs m | 1,689 | 21,438 | 7.9% | |
Share capital | Rs m | 262 | 67,682 | 0.4% | |
Net worth | Rs m | 2,635 | 96,141 | 2.7% | |
Long term debt | Rs m | 507 | 39,532 | 1.3% | |
Total assets | Rs m | 6,862 | 178,600 | 3.8% | |
Interest coverage | x | 2.6 | 1.8 | 139.5% | |
Debt to equity ratio | x | 0.2 | 0.4 | 46.8% | |
Sales to assets ratio | x | 1.0 | 0.3 | 296.0% | |
Return on assets | % | 12.4 | 7.3 | 171.3% | |
Return on equity | % | 17.3 | 5.5 | 313.3% | |
Return on capital | % | 31.0 | 10.3 | 300.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -313 | 8,539 | -3.7% | |
From Investments | Rs m | -489 | 877 | -55.7% | |
From Financial Activity | Rs m | 769 | -787 | -97.6% | |
Net Cashflow | Rs m | -33 | 8,630 | -0.4% |
Compare AMAR REMEDIES With: P&G (US) UNILEVER PLC. (UK)
Compare AMAR REMEDIES With: MARICO GODREJ CONSUMER BAJAJ CONSUMER CARE PIDILITE INDUSTRIES COLGATE
Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 160 points, down 0.3% at 50,685 levels.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this video, I'll show you how to allocate your capital as a day trader.
More